Aptra Synthesis

Infrastructure

Our Manufacturing facilities are equipped with Reactors from 50 L to 10 KL, ATFDs, RCVDs, VTDs, TDs, FBDs, ANFDs with a total reaction volume of 140KL at present and 250KL soon to be added. We are continuously investing in increasing our manufacturing capabilities to cater to demands of our esteemed clients.

Our process development and production capabilities in synthetic organic chemistry cover a wide therapeutic range of APIs and Intermediates. Our development expertise is backed by our comprehensive understanding of these processes and a strong R&D support. As a result, we provide you with high-quality APIs at competitive prices, while meeting the most stringent industry standards.

Our capabilities in the field of synthetic organic chemistry include:

Grignard Reaction, Chlorination, Hydrogenation, Oxidation, Friedel-Craft Reaction, Bromination, Sodium Hydride, Nitration, Amination, Esterification and many more.

Our most rigid analytical and physical control methods are utilized to deliver desired quality intermediates & APIs with stringent demands of regulatory bodies in target countries.

Our R & D experts continually strive to improve our processes so that you can benefit from capabilities in developing technologies to deliver and implement new processes that will enhance our production capabilities help you to maintain competitive edge in the marketplace.

Our significant investment in Process Development generates a steady flow of intermediates, enabling customers to go to market with new pharmaceutical products more quickly. About half of the team is dedicated to improving process efficiency and automation, to help customers reduce costs and remain competitive in the global marketplace.

We always get excited to help our customers stay a leading position in the marketplace. With our substantial ongoing investment in upgrading our plants and systems we will provide the best in quality APIs and intermediates at most competitive prices.